Steward Partners Investment Advisory’s Matinas BioPharma MTNB Stock Holding History

Steward Partners Investment Advisory’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-61	Closed	-$31	–	4794
2026 Q1	$31	Hold	61	–	–	﹤0.01%	4375
2025 Q4	$36	Hold	61	–	–	﹤0.01%	4262
2025 Q3	$115	Hold	61	–	–	﹤0.01%	4185
2025 Q2	$54	Hold	61	–	–	﹤0.01%	4060
2025 Q1	$32	Hold	61	–	–	﹤0.01%	3974
2024 Q4	$31	Hold	61	–	–	﹤0.01%	3944
2024 Q3	$216	Hold	61	–	–	﹤0.01%	3646
2024 Q2	$481	Hold	61	–	–	﹤0.01%	3472
2024 Q1	$824	Hold	61	–	–	﹤0.01%	3389
2023 Q4	$657	Hold	61	–	–	﹤0.01%	3336
2023 Q3	$395	Hold	61	–	–	﹤0.01%	3257
2023 Q2	$1.09K	Hold	61	–	–	﹤0.01%	3123
2023 Q1	$1.43K	Hold	61	–	–	﹤0.01%	3077
2022 Q4	$1.52K	Hold	61	–	–	﹤0.01%	3072
2022 Q3	$2K	Hold	61	–	–	﹤0.01%	3038
2022 Q2	$2K	Hold	61	–	–	﹤0.01%	3019
2022 Q1	$2K	Hold	61	–	–	﹤0.01%	3097
2021 Q4	$3K	Hold	61	–	–	﹤0.01%	2954
2021 Q3	$4K	Hold	61	–	–	﹤0.01%	2875
2021 Q2	$2K	Hold	61	–	–	﹤0.01%	6883
2021 Q1	$3.19K	Hold	61	–	–	﹤0.01%	3124
2020 Q4	$4K	Hold	61	–	–	﹤0.01%	2572
2020 Q3	$2K	Hold	61	–	–	﹤0.01%	2585
2020 Q2	$2K	Hold	61	–	–	﹤0.01%	2482
2020 Q1	$1K	Buy	+61	New	+$3.68K	﹤0.01%	2402

Other funds holding MTNB

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HIW

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Steward Partners Investment Advisory's MTNB Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Matinas BioPharma (MTNB) in Q2 2026, closing a stake of 61 shares — an estimated $31 sold.

Steward Partners Investment Advisory first reported a position in MTNB in Q1 2020 and held it in 25 quarters. The position peaked at $4K in Q3 2021. 25 funds tracked by Wall St. Rank hold MTNB as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Matinas BioPharma position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 61 Matinas BioPharma shares in Q2 2026, an estimated $31.
Steward Partners Investment Advisory first reported a position in Matinas BioPharma in Q1 2020 and held it in 25 quarters.
Steward Partners Investment Advisory's Matinas BioPharma position peaked at $4K in Q3 2021.
25 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.